Ambu A/S (AMBBY)
USD 14.18
(0.0%)
USD 14.18
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 2.55 Billion DKK | 6.01% |
| 2023 | 2.41 Billion DKK | -0.86% |
| 2022 | 2.43 Billion DKK | 12.44% |
| 2021 | 2.16 Billion DKK | 21.24% |
| 2020 | 1.78 Billion DKK | 54.19% |
| 2019 | 1.15 Billion DKK | 17.58% |
| 2018 | 984 Million DKK | 12.97% |
| 2017 | 871 Million DKK | 13.41% |
| 2016 | 768 Million DKK | 13.78% |
| 2015 | 675 Million DKK | 12.5% |
| 2014 | 600 Million DKK | 15.16% |
| 2013 | 521 Million DKK | 24.36% |
| 2012 | 418.94 Million DKK | 4.3% |
| 2011 | 401.66 Million DKK | 2.43% |
| 2010 | 392.14 Million DKK | 2.06% |
| 2009 | 384.23 Million DKK | -43.34% |
| 2008 | 678.18 Million DKK | 122.45% |
| 2007 | 304.87 Million DKK | 7.09% |
| 2006 | 284.68 Million DKK | 1.55% |
| 2005 | 280.34 Million DKK | 15.89% |
| 2004 | 241.9 Million DKK | 5.69% |
| 2003 | 228.87 Million DKK | -3.04% |
| 2002 | 236.05 Million DKK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 613 Million DKK | -0.81% |
| 2024 Q3 | 654 Million DKK | 5.65% |
| 2024 Q2 | 619 Million DKK | 0.98% |
| 2023 Q1 | 594 Million DKK | -8.76% |
| 2023 Q4 | 618 Million DKK | 6.37% |
| 2023 Q3 | 581 Million DKK | -5.99% |
| 2023 FY | 2.41 Billion DKK | -0.86% |
| 2023 Q2 | 618 Million DKK | 4.04% |
| 2022 Q2 | 600 Million DKK | 1.01% |
| 2022 Q1 | 594 Million DKK | -1.98% |
| 2022 Q3 | 587 Million DKK | -2.17% |
| 2022 FY | 2.43 Billion DKK | 12.44% |
| 2022 Q4 | 651 Million DKK | 10.9% |
| 2021 Q2 | 523 Million DKK | 1.75% |
| 2021 Q3 | 520 Million DKK | -0.57% |
| 2021 Q4 | 606 Million DKK | 16.54% |
| 2021 Q1 | 514 Million DKK | 1.58% |
| 2021 FY | 2.16 Billion DKK | 21.24% |
| 2020 Q4 | 506 Million DKK | 10.72% |
| 2020 Q2 | 457 Million DKK | 25.55% |
| 2020 FY | 1.78 Billion DKK | 54.19% |
| 2020 Q1 | 364 Million DKK | 14.47% |
| 2020 Q3 | 457 Million DKK | 0.0% |
| 2019 Q2 | 277 Million DKK | -1.42% |
| 2019 Q1 | 281 Million DKK | 6.04% |
| 2019 FY | 1.15 Billion DKK | 17.58% |
| 2019 Q4 | 318 Million DKK | 13.17% |
| 2019 Q3 | 281 Million DKK | 1.44% |
| 2018 Q1 | 230 Million DKK | 0.88% |
| 2018 FY | 984 Million DKK | 12.97% |
| 2018 Q2 | 238 Million DKK | 3.48% |
| 2018 Q3 | 251 Million DKK | 5.46% |
| 2018 Q4 | 265 Million DKK | 5.58% |
| 2017 Q2 | 220 Million DKK | 4.76% |
| 2017 FY | 871 Million DKK | 13.41% |
| 2017 Q4 | 228 Million DKK | 7.04% |
| 2017 Q3 | 213 Million DKK | -3.18% |
| 2017 Q1 | 210 Million DKK | -1.87% |
| 2016 Q3 | 181 Million DKK | -2.16% |
| 2016 FY | 768 Million DKK | 13.78% |
| 2016 Q4 | 214 Million DKK | 18.23% |
| 2016 Q1 | 188 Million DKK | 26.17% |
| 2016 Q2 | 185 Million DKK | -1.6% |
| 2015 Q3 | 176 Million DKK | -3.83% |
| 2015 Q4 | 149 Million DKK | -15.34% |
| 2015 FY | 675 Million DKK | 12.5% |
| 2015 Q1 | 167 Million DKK | 15.97% |
| 2015 Q2 | 183 Million DKK | 9.58% |
| 2014 Q3 | 150 Million DKK | 1.35% |
| 2014 Q4 | 144 Million DKK | -4.0% |
| 2014 Q1 | 159 Million DKK | 14.55% |
| 2014 Q2 | 148 Million DKK | -6.92% |
| 2014 FY | 600 Million DKK | 15.16% |
| 2013 Q4 | 138.8 Million DKK | -3.07% |
| 2013 FY | 521 Million DKK | 24.36% |
| 2013 Q3 | 143.2 Million DKK | 13.11% |
| 2013 Q2 | 126.6 Million DKK | 12.63% |
| 2013 Q1 | 112.4 Million DKK | 9.93% |
| 2012 Q4 | 102.24 Million DKK | -2.25% |
| 2012 Q1 | 107 Million DKK | 9.23% |
| 2012 FY | 418.94 Million DKK | 4.3% |
| 2012 Q2 | 105.6 Million DKK | -1.31% |
| 2012 Q3 | 104.6 Million DKK | -0.95% |
| 2011 Q2 | 104 Million DKK | 2.06% |
| 2011 Q1 | 101.9 Million DKK | -3.45% |
| 2011 Q3 | 97.9 Million DKK | -5.87% |
| 2011 Q4 | 97.96 Million DKK | 0.06% |
| 2011 FY | 401.66 Million DKK | 2.43% |
| 2010 Q1 | 93.9 Million DKK | -22.99% |
| 2010 Q4 | 105.54 Million DKK | 7.48% |
| 2010 FY | 392.14 Million DKK | 2.06% |
| 2010 Q3 | 98.2 Million DKK | 3.92% |
| 2010 Q2 | 94.5 Million DKK | 0.64% |
| 2009 Q4 | 121.93 Million DKK | 39.35% |
| 2009 FY | 384.23 Million DKK | -43.34% |
| 2009 Q1 | 86 Million DKK | 0.0% |
| 2009 Q3 | 87.5 Million DKK | -1.57% |
| 2009 Q2 | 88.9 Million DKK | 3.37% |
| 2008 FY | 678.18 Million DKK | 122.45% |
| 2007 FY | 304.87 Million DKK | 7.09% |
| 2006 FY | 284.68 Million DKK | 1.55% |
| 2005 FY | 280.34 Million DKK | 15.89% |
| 2004 FY | 241.9 Million DKK | 5.69% |
| 2003 FY | 228.87 Million DKK | -3.04% |
| 2002 FY | 236.05 Million DKK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AVITA Medical, Inc. | 80.77 Million USD | -3064.18% |
| Manhattan Scientifics, Inc. | 703 Thousand USD | -363484.637% |
| Össur hf. | 396.18 Million USD | -545.152% |
| QHSLab, Inc. | 961.65 Thousand USD | -265692.339% |
| Wellstar International, Inc. | 1.79 Million USD | -142319.663% |
| Össur hf. | 396.18 Million USD | -545.152% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | -48579.52% |
| Aurora Spine Corporation | 8.65 Million USD | -29423.575% |
| BrainsWay Ltd. | 28.01 Million USD | -9022.707% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 740.67 Thousand USD | -344990.161% |
| Hamilton Thorne Ltd. | 33.57 Million USD | -7513.359% |
| Vivos Inc. | 2.78 Million USD | -91607.898% |
| Kelyniam Global, Inc. | 2.27 Million USD | -112239.6% |
| REMSleep Holdings, Inc. | 1.01 Million USD | -251746.728% |
| Zecotek Photonics Inc. | 3.46 Million USD | -73741.972% |
| Avitar, Inc. | 3.56 Million USD | -71506.407% |
| Nanomix Corporation | 8.36 Million USD | -30445.992% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | -11636.615% |
| Theraclion SA | 7.43 Million USD | -34255.614% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | 1 Million USD | -253651.421% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | -82074.711% |
| Lombard Medical, Inc. | 30.29 Million USD | -8338.429% |
| ALR Technologies Inc. | 6.33 Million USD | -40240.935% |
| Stratec SE | 46.32 Million USD | -5418.09% |
| Vycor Medical, Inc. | 1.27 Million USD | -200297.816% |
| Heart Tronics, Inc. | 14.46 Million USD | -17576.246% |
| MicroPort Scientific Corporation | 1.04 Billion USD | -143.832% |
| VMS Rehab Systems, Inc. | 63.63 USD | -4016973025.884% |
| NewCardio, Inc. | 9.56 Million USD | -26624.27% |
| Guided Therapeutics, Inc. | 3.49 Million USD | -73074.921% |
| Ingen Technologies, Inc. | 1.88 Million USD | -135697.019% |
| Odyssey Group International, Inc. | -14.26 Million USD | 18022.913% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | -586811.596% |
| Wellness Center USA, Inc. | 1.29 Million USD | -197338.857% |
| SANUWAVE Health, Inc. | 14.15 Million USD | -17962.328% |
| IR-Med Inc. | 4.89 Million USD | -52127.217% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -1238158.106% |
| Polarean Imaging plc | 12.24 Million USD | -20778.157% |
| United American Healthcare Corporation | 59 Thousand USD | -4332103.39% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | -627162.353% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -2120604.246% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | -402617.556% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | -150646.211% |
| Medical Supply International USA, Inc. | 1.32 Million USD | -193463.631% |
| Urologix, Inc. | 10.09 Million USD | -25226.992% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | -202221.953% |
| Nexeon MedSystems Inc. | 5.94 Million USD | -42870.246% |
| SS Innovations International, Inc. | 21.38 Million USD | -11854.081% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | -1110041.113% |
| Smith & Nephew plc | 3.46 Billion USD | 26.276% |
| NIOX Group Plc | 22.27 Million USD | -11373.46% |
| Fuse Medical, Inc. | 10.35 Million USD | -24595.616% |
| Broncus Holding Corporation | 38.15 Million USD | -6599.685% |
| Brain Scientific Inc. | 9.66 Million USD | -26352.146% |
| Pressure BioSciences, Inc. | 10.3 Million USD | -24708.501% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -4210911.895% |